| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ZoomMed Inc (CVE: ZMD)
ZMD Technical Analysis
4
| As on 4th Oct 2017 ZMD Share Price closed @ 0.02 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.02 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZMD Share Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.00 | 0.00 |
| Low | 0.02 | 1 Week | 0.00 | 0.00 |
| Close | 0.02 | 1 Month | 0.00 | 0.00 |
| Volume | 7712 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.04 | 52 Week Low 0.01 | ||||
CVE Canada Most Active Stocks
| PRY | 0.02 | 0.00% |
| PUM | 0.11 | 37.50% |
| GLK | 0.06 | 50.00% |
| COD | 0.07 | 0.00% |
| DVN | 0.17 | 0.00% |
| LTV | 0.57 | -1.72% |
| RPL | 2.00 | 3.09% |
| PI | 0.18 | 0.00% |
| GOD | 0.02 | 0.00% |
| SUG | 0.10 | 0.00% |
CVE Canada Top Gainers Stocks
CVE Canada Top Losers Stocks
| ZMD Daily Charts |
ZMD Intraday Charts |
Whats New @ Bazaartrend |
ZMD Free Analysis |
|
|
ZMD Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
ZMD Target for Month June
| 4th UP TARGET | 0.02 |
| 3rd UP TARGET | 0.02 |
| 2nd UP TARGET | 0.02 |
| 1st UP TARGET | 0.02 |
| 1st DOWN TARGET | 0.02 |
| 2nd DOWN TARGET | 0.02 |
| 3rd DOWN TARGET | 0.02 |
| 4th DOWN TARGET | 0.02 |
ZMD Weekly Target
| 4th UP TARGET | 0.00 |
| 3rd UP TARGET | 0.00 |
| 2nd UP TARGET | 0.00 |
| 1st UP TARGET | 0.00 |
| 1st DOWN TARGET | 0.00 |
| 2nd DOWN TARGET | 0.00 |
| 3rd DOWN TARGET | 0.00 |
| 4th DOWN TARGET | 0.00 |
ZMD Target for Year 2020
| 4th UP TARGET | 0 |
| 3rd UP TARGET | 0 |
| 2nd UP TARGET | 0 |
| 1st UP TARGET | 0 |
| 1st DOWN TARGET | 0 |
| 2nd DOWN TARGET | 0 |
| 3rd DOWN TARGET | 0 |
| 4th DOWN TARGET | 0 |
ZoomMed Inc ( CVE Canada Symbol : ZMD )
Sector : Technology And Other Stocks in Same Sector
Sector : Technology And Other Stocks in Same Sector
ZMD Business Profile
Zoommed Inc. develops and markets various computer applications for healthcare professionals in Canada. The company builds and operates the ZoomMed Communication Network, a clinical interoperable information exchange network between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations, laboratories, specialized clinics private insurers, employers, and others. It develops the ZRx Prescriber, a Web application that enables physicians to use a wireless device, such as the IPod Touch, IPhone, IPad, Google Android, other PDAÂ’s or computers to write prescriptions and renewals. The company also offers PraxisLab, a pharmacy management software, which enhances various aspects of the prescription filling process and the complete pharmacists patient file management. In addition, it provides EvPsych, an Electronic Medical Record built for behavioral health practitioners. The company was incorporated in 2005 and is headquartered in Brossard, Canada.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
